Active Digestion, Kidneys & Other Organs Public Health & Healthcare

Improving recommendations for schistosomiasis control interventions using interdisciplinary techniques

In plain English

AI plain-English summary

A single dose of praziquantel, the main drug against schistosomiasis, often fails to clear the infection, and many people avoid taking it because of its side-effects. This project tackles two concrete problems undermining mass drug administration campaigns in affected regions. First, the researcher will identify which individual factors—such as genetics, co-infections, or drug quality—cause praziquantel to work poorly in some people. Second, they will formally evaluate whether taking the drug with food boosts its absorption and reduces side-effects, a practice that has never been rigorously tested. Third, they will survey communities in endemic areas to find out which water, sanitation, and hygiene (WASH) interventions people actually prefer and will use, rather than assuming what works. If successful, the research could directly improve how schistosomiasis control programmes are run. Health officials could tailor drug regimens based on confirmed causes of treatment failure, recommend food co-administration with clear evidence, and invest in WASH measures that communities will adopt. These changes would make mass drug campaigns more effective, reduce reinfection rates, and accelerate progress toward eliminating a disease that sickens hundreds of millions of people. The work is applied and intervention-focused, with no fundamental science component.

View original technical description
Schistosomiasis is a neglected tropical disease that causes significant morbidity in infected populations of endemic regions. The cornerstone of control efforts is mass drug administration (MDA) campaigns using praziquantel, which are being executed with varying degrees of success. Many individual-related factors are associated with the suboptimal efficacy of praziquantel, leading to MDAs treatment failures, but these causal relationships have not been confirmed. Additionally, MDA compliance is negatively affected by praziquantel’s side-effects, and although there is evidence to suggest that the concomitant administration of praziquantel with food increases the drugs’ bioavailability and decreases its side-effects, this evidence has not been formally evaluated. MDAs are augmented by water, sanitation, and hygiene (WASH) based interventions to decrease disease transmission and reduce re-infection. To succeed, communities of affected areas must be willing to uptake these interventions; nonetheless, it is unknown which specific WASH interventions targeted populations prefer. I will quantify potential causes of poor praziquantel efficacy, evaluate evidence of food’s impact on praziquantel’s pharmacokinetics, side-effects, and efficacy, and examine which WASH interventions are more popular and therefore more likely to be used by targeted populations. Overall, my project will improve knowledge to enhance schistosomiasis intervention methods in endemic areas to help accelerate elimination efforts.

View the original record at the funder ↗

Researchers

Farah Hamdan (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Cultural, social and economic influences on ongoing Schistosoma mansoni transmission, despite a decade of mass treatment, and the potential for change
New approaches to characterise Schistosoma mansoni infections persisting despite mass drug administration
The development of molecular diagnostics for antihelmintic drug resistance monitoring in human schistosomiasis.
WISER-Water Infrastructure for Schistosomiasis-Endemic Regions
Optimizing strategies to diagnose and control intestinal Schistosomiasis in low and moderate endemicity areas of Brazil

Original classification

PhD Studentship (Basic)

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.